Clinical Trial: Weight and BMI Patterns in Biological Based IBD Patients and Its Finacial Impact

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07495800) titled 'Weight and BMI Patterns in Biological Based IBD Patients and Its Finacial Impact' on March 16.

Brief Summary: Primary Objective To determine the pattern of weight and body mass index (BMI) changes in biologic-treated patients with inflammatory bowel disease (IBD).

Secondary Objectives To evaluate the correlation between BMI and biologic drug dosing. To estimate the direct financial burden of biologic therapy according to BMI categories.

To assess whether higher BMI is associated with increased treatment requirements.

Study Start Date: May 01

Study Type: OBSERVATIONAL

Condition: Weight Changes Biologic IBD

Recruitment Status:...